For instance, neurofilament light chain (NfL) has emerged as a robust biomarker of neurodegeneration, providing valuable insights into disease progression in Alzheimer’s disease (AD), Parkinson’s disease (PD), multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS). This evidence concerns the gene NEFL and amyotrophic lateral sclerosis.